Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Dexamethasone Sodium Phosphate Injection
Status: Currently in Shortage
»Date first posted:
02/08/2019
»Therapeutic Categories: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Eugia US LLC (Revised 02/19/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 55150-237-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 55150-238-05) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 55150-239-30) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 100 mg/10 mL (NDC 55150-305-10) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 03/04/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-106-10) | Unavailable | Not available at this time. | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-109-10) | Unavailable | Backordered. Next release March 2025. Check wholesaler for inventory. | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Available | Check wholesalers for inventory. | |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Available | Check wholesaler inventory | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Available | 8 month expiry available upon request. Check wholesaler for inventory. | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Available | Check wholesalers for inventory. | |
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Unavailable | Backordered. Next release March 2025. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Reverified 02/14/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Available | Currently available. Additional product will be made available as it is released. | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Unavailable | Additional lots will be available in the February - March 2025 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Unavailable | Additional lots will be available in the February 2025 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Mylan Institutional, a Viatris Company (Reverified 02/24/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Available | ||
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Available | ||
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Available | ||
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Available |
Somerset Therapeutics, LLC (Reverified 02/28/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | Available |